Dipyrone (metamizole), overrated risks? / Dipirona, ¿riesgos sobredimensionados?
Rev. colomb. anestesiol
;
47(4): 257-259, Oct-Dec. 2019. tab
Article
in English
| LILACS, COLNAL
| ID: biblio-1042738
ABSTRACT
In their editorial, Gómez-Duarte1 suggests that the association of dipyrone with multiple adverse effects should lead to reconsider its use. We are of the opinion that such position neglects part of the available evidence, although we recognize that based on such evidence different views arise with regard to its use.2,3 Dipyrone is an analgesic agent widely used by the Colombian anesthesiologists. In our country, we have accumulated a vast experience in the area of acute postoperative pain and it is fundamental to assess the available evidence to determine the role of dipyrone in the practice of anesthesia in Colombia.
RESUMEN
En su editorial, Gómez-Duarte1 sugiere que la asociación de la dipirona con múltiples efectos adversos debería llevar a reconsiderar su uso. Somos de la opinión de que tal posición descuida parte de la evidencia disponible, aunque reconocemos que con base en dicha evidencia surgen diferentes puntos de vista con respecto a su uso.2,3 La dipirona es un agente analgésico ampliamente utilizado por los anestesiólogos colombianos. En nuestro país hemos acumulado una amplia experiencia en el área del dolor agudo postoperatorio y es fundamental evaluar la evidencia disponible para determinar el papel de la dipirona en la práctica de la anestesia en Colombia.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Dipyrone
Type of study:
Etiology study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Rev. colomb. anestesiol
Journal subject:
Anesthesiology
Year:
2019
Type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Fundación Hospital de la Misericordia/CO
Similar
MEDLINE
...
LILACS
LIS